A prospective, multicenter, double-blind, randomized, comparative study to evaluate the safety, local tolerability, and clinical outcome of ertapenem versus ceftriaxone in pediatric patients with complicated urinary tract infection, skin and soft tissue infection, or community-acquired pneumonia

Trial Profile

A prospective, multicenter, double-blind, randomized, comparative study to evaluate the safety, local tolerability, and clinical outcome of ertapenem versus ceftriaxone in pediatric patients with complicated urinary tract infection, skin and soft tissue infection, or community-acquired pneumonia

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Feb 2017

At a glance

  • Drugs Ceftriaxone; Ertapenem
  • Indications Bacterial infections; Community-acquired pneumonia; Skin and soft tissue infections; Urinary tract infections
  • Focus Adverse reactions
  • Sponsors Merck & Co
  • Most Recent Events

    • 29 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top